Literature DB >> 10665648

Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.

H Takahashi1, Y Hosokawa, R Suzuki, Y Morishima, S Nakamura, M Seto.   

Abstract

The BCL10 gene was recently isolated from the breakpoint region of t(1;14)(p22;q32) in mucosa-associated lymphoid tissue (MALT) lymphomas. Somatic mutations of BCL10 were found in not only t(1;14)-bearing MALT lymphomas, but also a wide range of other tumors. To clarify the actual frequency and spectrum of BCL10 mutations in primary B-cell non-Hodgkin's lymphomas (NHL), we examined a total of 139 NHL cases comprising 25 with MALT lymphomas, 54 with follicular B-cell lymphomas (FCL), and 60 with diffuse large B-cell lymphomas (DLBL). Polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) and sequencing analyses led to the identification of four nucleotide changes in FCL and one in DLBL. In contrast, no BCL10 mutations were found in our series of MALT lymphomas. While screening for mutations, we also found three polymorphic sequence variants at codons 5 and 213 and in intron 1 of the BCL10 gene. Our results strongly suggest that somatic mutations of BCL10, if they occur at all, are rare in B-cell NHLs and do not commonly contribute to their molecular pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10665648      PMCID: PMC5926036          DOI: 10.1111/j.1349-7006.1999.tb00714.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  27 in total

1.  The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.

Authors:  G Ott; T Katzenberger; A Greiner; J Kalla; A Rosenwald; U Heinrich; M M Ott; H K Müller-Hermelink
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

2.  Molecular cytogenetic delineation of the breakpoint at 18q21.1 in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  T Akagi; A Tamura; M Motegi; R Suzuki; Y Hosokawa; S Nakamura; Y Morishima; M Seto; M Taniwaki
Journal:  Genes Chromosomes Cancer       Date:  1999-04       Impact factor: 5.006

3.  The biology of low grade MALT lymphoma.

Authors:  P G Isaacson; J Spencer
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

4.  Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization.

Authors:  J Dierlamm; L Michaux; I Wlodarska; S Pittaluga; W Zeller; M Stul; A Criel; J Thomas; M Boogaerts; P Delaere; J J Cassiman; C de Wolf-Peeters; C Mecucci; H Van den Berghe
Journal:  Br J Haematol       Date:  1996-04       Impact factor: 6.998

5.  The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas.

Authors:  J Dierlamm; M Baens; I Wlodarska; M Stefanova-Ouzounova; J M Hernandez; D K Hossfeld; C De Wolf-Peeters; A Hagemeijer; H Van den Berghe; P Marynen
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

6.  Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue.

Authors:  A C Wotherspoon; T M Finn; P G Isaacson
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

7.  Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

Authors:  Q Zhang; R Siebert; M Yan; B Hinzmann; X Cui; L Xue; K M Rakestraw; C W Naeve; G Beckmann; D D Weisenburger; W G Sanger; H Nowotny; M Vesely; E Callet-Bauchu; G Salles; V M Dixit; A Rosenthal; B Schlegelberger; S W Morris
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

Review 8.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

9.  Bcl10 is not a target for frequent mutation in human carcinomas.

Authors:  A R Lambers; C Gumbs; S Ali; J R Marks; J D Iglehart; A Berchuck; P A Futreal
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

10.  Bcl10 mutations in malignancy.

Authors:  M J Dyer
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

View more
  2 in total

1.  Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.

Authors:  J Tadokoro; Y Nakamura; S Furusawa; K Mitani
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

2.  Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma.

Authors:  Dana J Wallace; DeFen Shen; George F Reed; Masaru Miyanaga; Manabu Mochizuki; H Nida Sen; Samuel S Dahr; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.